Seaport Therapeutics, Inc. (SPTX)
17.15
-1.00
(-5.51%)
USD |
NASDAQ |
Oct 12, 16:00
17.09
-0.06
(-0.35%)
After-Hours: 20:00
Seaport Therapeutics Enterprise Value : 649.76M for Oct. 12, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| October 12, 2026 | 649.76M |
| October 09, 2026 | 703.29M |
| October 08, 2026 | 690.44M |
| October 07, 2026 | 691.51M |
| October 06, 2026 | 661.53M |
| October 05, 2026 | 722.02M |
| October 02, 2026 | 717.74M |
| October 01, 2026 | 746.11M |
| September 30, 2026 | 811.42M |
| September 29, 2026 | 732.19M |
| September 28, 2026 | 783.05M |
| September 25, 2026 | 883.69M |
| September 24, 2026 | 862.27M |
| September 23, 2026 | 871.37M |
| September 22, 2026 | 930.26M |
| September 21, 2026 | 862.27M |
| September 18, 2026 | 876.73M |
| September 17, 2026 | 899.74M |
| September 16, 2026 | 916.87M |
| September 15, 2026 | 960.77M |
| September 14, 2026 | 1.054B |
| September 11, 2026 | 981.11M |
| September 10, 2026 | 977.90M |
| September 09, 2026 | 896.00M |
| September 08, 2026 | 1.020B |
| Date | Value |
|---|---|
| September 04, 2026 | 1.062B |
| September 03, 2026 | 1.032B |
| September 02, 2026 | 1.065B |
| September 01, 2026 | 995.56M |
| August 31, 2026 | 999.31M |
| August 28, 2026 | 1.019B |
| August 27, 2026 | 1.137B |
| August 26, 2026 | 1.222B |
| August 25, 2026 | 1.061B |
| August 24, 2026 | 1.021B |
| August 21, 2026 | 1.033B |
| August 20, 2026 | 1.018B |
| August 19, 2026 | 1.039B |
| August 18, 2026 | 1.015B |
| August 17, 2026 | 1.038B |
| August 14, 2026 | 1.028B |
| August 13, 2026 | 1.001B |
| August 12, 2026 | 1.006B |
| August 11, 2026 | 982.18M |
| August 10, 2026 | 963.98M |
| August 07, 2026 | 996.10M |
| August 06, 2026 | 967.73M |
| August 05, 2026 | 927.58M |
| August 04, 2026 | 878.87M |
| August 03, 2026 | 837.11M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Johnson & Johnson | 663.40B |
| Bristol Myers Squibb Co. | 151.62B |
| Harmony Biosciences Holdings, Inc. | 1.775B |
| ANI Pharmaceuticals, Inc. | 1.925B |
| Corcept Therapeutics, Inc. | 12.78B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -62.60M |
| Total Expenses (Quarterly) | 62.60M |
| EPS Diluted (Quarterly) | -1.169 |
| Earnings Yield | -12.66% |
| Normalized Earnings Yield | -12.66 |